Clinical Trial Update: HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)

View source ↗

Summary

The HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I.) trial is currently active but not recruiting, per the sponsor Université de Sherbrooke. It in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperaldosteronism
• Hypertensive Disorder of Pregnancy

Snippet

Sponsor: Université de Sherbrooke | Conditions: Primary Hyperaldosteronism, Hypertensive Disorder of Pregnancy | Status: ACTIVE_NOT_RECRUITING